CYHB1950319 | 注射用盐酸头孢吡肟 | cefepime hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2019-05-05 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-11-10 | view |
CYHB1950318 | 注射用盐酸头孢吡肟 | cefepime hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2019-05-05 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-11-10 | view |
CYHB2010848 | 左乙拉西坦片 | levetiracetam | Tablet | Chemical Drugs | Supplementary Application | 2020-12-18 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-09-13 | view |
CYHS1700616 | 西他沙星片 | sitafloxacin | Tablet | Chemical Drugs(3) | Generic Drug | 2018-07-06 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-07-28 | view |
CYHS1800472 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs(4) | Generic Drug | 2018-12-17 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-07-08 | view |
CYHS1800471 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs(4) | Generic Drug | 2018-12-17 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-07-08 | view |
CYHS1900403 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Generic Drug | 2019-06-27 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-03-26 | view |
CYHB2011188 | 硫酸氢氯吡格雷片 | clopidogrel bisulfate | Tablet | Chemical Drugs | Supplementary Application | 2020-12-24 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-03-25 | view |
CYHB2100212 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-02-03 | view |
CYHB2100211 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-02-03 | view |
CYHS1900134 | 利伐沙班片 | rivaroxaban | Tablet | Chemical Drugs(4) | Generic Drug | 2019-02-19 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-02-03 | view |
CXHB2100022 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Accepted | 2021-02-02 | view |
CXHB2100023 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Accepted | 2021-02-02 | view |
CXHL2100022 | SAL0104胶囊 | SAL-0104 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-01-16 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-15 | view |
CXHL2100023 | SAL0104胶囊 | SAL-0104 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-01-14 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-13 | view |
CXHL2100020 | SAL0104胶囊 | SAL-0104 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-01-13 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-12 | view |
CXHL2100021 | SAL0104胶囊 | SAL-0104 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-01-13 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-12 | view |
CXHL2100011 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2021-01-09 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-08 | view |
CYHB1906531 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-11-27 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-01-08 | view |
CYHB2007104 | 阿利沙坦酯片 | allisartan isoproxil | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-21 | view |